Pence to lead Trump transition team, replacing Christie as chairman
Donald Trump picked his transition chairman and other leaders Friday. It’s his biggest staffing announcement since he won the election this week.
Bloomberg News
Articles
Drugmakers’ stocks jump on promise of Trump presidency
Pharmaceutical company stocks were among the winners in early trading Wednesday as Republicans’ sweeping election victory eased concerns that Democrats would enact controls on drug prices. Eli Lilly and Co. shares jumped 4 percent.
Global markets rocked as traders see pathway for Trump victory
Global markets were thrown into disarray as early results from the U.S. election raised the possibility that Donald Trump may prevail over Hillary Clinton in the race for the presidency.
Dow-DuPont merger hits delays as EU demands missing deal info
Dow Agrosciences parent Dow Chemical Co. and DuPont Co. face further delays to their plans to create the world’s biggest chemical company
Cubs’ World Series clincher tops 40 million viewers
The World Series ended on an incredibly high note, with the 8-7 victory by the Chicago Cubs over the Cleveland Indians ranking as the most-watched baseball game in 25 years.
Here’s how Cubs championship hats get to stores so fast
Cubs fans had been waiting more than a century for this triumph, and the rush for celebratory merchandise is on. Zionsville-based Lids Sports Group is using extra workers to make sure key stores have caps available as soon as possible.
Anthem threatens Obamacare retreat if results don’t improve
If Indianapolis-based Anthem retreats from the Affordable Care Act, it would mean that almost all of the major American for-profit health insurers have substantially pulled back from the law.
Lilly shares slip after Bernie Sanders criticizes insulin prices
Makers of insulin became the latest target for Sen. Bernie Sanders, who has been going after pharmaceutical companies one by one over the issue of high U.S. drug prices.
Dow Agro sales rise on strong demand for seeds
Indianapolis-based Dow AgroSciences said sales and operating earnings rose in the third quarter, thanks in part to strong demand for products in Latin America. Meanwhile, the massive merger between parent Dow Chemical and DuPont has been delayed.
Drug firms fighting ‘tooth and nail’ against California ballot measure
Drugmakers including Eli Lilly and Co. are becoming increasingly vocal in fighting a California ballot proposition designed to bring down prices on prescription medicine.
AT&T-Time Warner’s $85B deal faces regulatory cloud
AT&T Inc.’s planned $85 billion takeover of Time Warner Inc. mirrors Comcast Corp.’s successful acquisition of NBCUniversal, but the latest pairing faces a potentially rockier path through Washington, D.C.
Dow-DuPont’s modified corn fails to control pest, scientists say
Corn containing the Herculex trait isn’t controlling the western bean cutworm, six entomologists from Michigan, Indiana, Ohio, New York and Pennsylvania wrote in an " open letter to the seed industry" posted on the website of Purdue University.
Activist asks Simon Property competitor to consider sale
Shares in Taubman Centers Inc. surged Wednesday, one day after Jonathan Litt, an activist investor known for targeting real estate companies, pushed for the mall owner to cut costs or consider a sale of the company.
Princeton to pay $18 million to settle residents’ tax case
The residents who sued sought to revoke the school’s property-tax exemption, in part because Princeton shares commercial royalties with faculty from a patent that Indianapolis-based Eli Lilly and Co. turned into the cancer drug Alimta.
Obamacare enrollment predicted to see ‘significant slowdown’ next year
Enrollment in the Obamacare insurance marketplace is likely to stall or even decline for 2017 after two years of growth, according to S&P Global Ratings forecasts.
Ag giants’ smaller rivals see big opportunity amid mergers
Farmers may be worried about the multibillion-dollar deals transforming the agriculture industry, but independent seed companies like Indiana-based Beck’s Hybrids see the consolidation as an opportunity.
Pence praises debater Trump, squelches talk of quitting ticket
Presidential nominee Donald Trump on Monday received full support from running mate Mike Pence, who shut down talk of quitting the ticket despite his disapproval of Trump’s crude remarks about women. Pence also downplayed any disagreement with Trump over their stance on Syria.
GOP calls grow for Trump to step aside in favor of Pence
A chorus of Republican leaders on Saturday said vice presidential nominee Mike Pence is well suited to move to the top of the ticket if they can persuade Donald Trump to quit.
GOP calls grow for Trump to step aside in favor of Pence
A chorus of Republican leaders on Saturday said vice presidential nominee Mike Pence is well suited to move to the top of the ticket if they can persuade Donald Trump to quit.
Pence says he won’t ‘condone’ or ‘defend’ Trump’s remarks about women
The vice presidential nominee said he was "offended by the words and actions described by Donald Trump," and he called on the GOP presidential nomineee "to show what is in his heart" when he appears at Sunday night's presidential debate.